Fabtech Technologies Ltd schedules Q2 FY27 investor call
Key highlights
- Fabtech Technologies scheduled its Q2 FY27 post-earnings conference call for October 30, 2026, at 2:00 p.m.
- Fabtech Technologies reported Q1 FY27 consolidated revenue of ₹74.98 crore, up 10% year on year.
- Fabtech Technologies posted Q1 FY27 EBITDA of ₹7.41 crore and an EBITDA margin of 9%.
- Fabtech Technologies returned to profitability in Q1 FY27 with consolidated net profit of ₹4.21 crore, versus a ₹6.13 crore loss a year earlier.
powered by IRIS

Fabtech Technologies Ltd scheduled a post-earnings conference call for October 30, 2026, following the release of unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026. The update matters because Fabtech Technologies entered FY27 with Q1 revenue of ₹74.98 crore, 10% higher year on year, and a return to profitability.
Know Fabtech Technologies inside out
Results, valuation, peers and who's buying, in one view.
What did Fabtech Technologies Ltd announce for Q2 FY27?
Fabtech Technologies Ltd announced that its post-earnings conference call was scheduled for 2:00 p.m. on October 30, 2026. The company issued the notice under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and provided a registration link for the call.
The filing followed the release of the company's unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Fabtech Technologies also said that an investor presentation relating to those results had been attached to its exchange communication.
The available material does not provide the company's Q2 FY27 revenue, EBITDA, net profit, order book, or margin figures. It also states that the recording and transcript of the Q2 earnings call were not yet available. Therefore, any detailed assessment of the September-quarter performance requires the financial results and investor presentation themselves, rather than the call notice alone.
Why is the Q2 FY27 call relevant for investors?
The Q2 FY27 call is relevant because it gives investors an opportunity to assess whether Fabtech Technologies has sustained the operational recovery reported in the June quarter. In Q1 FY27, the company reported consolidated revenue of ₹74.98 crore, compared with ₹68.01 crore in Q1 FY26.
More notably, Fabtech Technologies reported a consolidated net profit of ₹4.21 crore in Q1 FY27, against a net loss of ₹6.13 crore in the corresponding quarter of the previous year. EBITDA was ₹7.41 crore, with an EBITDA margin of 9%, compared with negative EBITDA of ₹5.27 crore in Q1 FY26.
Management had attributed the Q1 outcome to profitable execution despite a challenging global environment, geopolitical uncertainty in parts of its operating geography, and higher freight costs. During that call, it also stated that it remained confident of delivering organic growth of 20% to 25% for the full financial year.
What business does Fabtech Technologies operate in?
Fabtech Technologies is a turnkey engineering, design and build company serving pharmaceutical, healthcare, biotechnology and life-sciences customers. It designs and builds facilities used for manufacturing medicines, vaccines and medical devices.
Its stated scope includes cleanrooms, heating, ventilation and air-conditioning systems, process utilities, containment suites and complete greenfield Good Manufacturing Practice plants. The company describes its offering as a single-point-responsibility model for such projects.
This operating model makes project execution, customer demand, equipment and freight costs, and conditions in overseas markets relevant to financial performance. The company's Q1 commentary referred to geopolitical uncertainty and warlike conditions in parts of its operating geography, alongside a sharp increase in freight costs.
Got a follow-up? Ask IRIS
How did Fabtech Technologies perform before the Q2 update?
Fabtech Technologies' Q1 FY27 results showed both revenue growth and a recovery in profitability versus the prior-year quarter. Revenue grew 10.3% year on year, while contribution margin increased from 37.6% to 46.7%.
The shift from a ₹6.13 crore net loss to a ₹4.21 crore net profit was accompanied by positive EBITDA of ₹7.41 crore. These reported figures provide the most recent detailed financial reference available in the supplied information before the Q2 FY27 communication.
The company also held earnings calls for Q4 FY26 and Q3 FY26 on April 28, 2026, and February 14, 2026, respectively. Its Q1 FY27 call was held on July 28, 2026. The October 30 event was the next scheduled investor interaction in that sequence.
What should investors track in the Q2 FY27 disclosures?
Investors should track the reported Q2 FY27 revenue, profitability, margins and management commentary on the full-year organic growth range of 20% to 25%. The supplied announcement confirms that unaudited results and an investor presentation were issued, but it does not disclose their financial details.
The call may also provide management's latest comments on project execution, overseas operating conditions, freight costs and working-capital efficiency. In Q1, Fabtech Technologies identified profitable growth, disciplined execution, stronger working-capital efficiency and geographic diversification as areas of focus.
For shareholders and market participants, the key issue is whether the June-quarter move into positive EBITDA and net profit continued through the September quarter. That conclusion cannot be drawn from the call scheduling announcement alone, as the relevant Q2 figures are not included in the available text.
Conclusion
Fabtech Technologies has scheduled its Q2 FY27 investor call after issuing unaudited results for the quarter and half-year ended September 30, 2026. The event follows a Q1 FY27 performance in which revenue reached ₹74.98 crore, EBITDA turned positive at ₹7.41 crore, and net profit was ₹4.21 crore.
The next item to watch is the company's detailed Q2 financial disclosure and subsequent earnings-call recording or transcript. Investors will be able to compare the September-quarter outcome with management's stated FY27 organic growth objective of 20% to 25% and its focus on margins, execution and working-capital efficiency.


